Conventional Postoperative Radiotherapy (Standard Fractionation) Plus Iressa [gefitinib] or Hyperfractionated Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer: A Phase I Pilot Trial

Trial Profile

Conventional Postoperative Radiotherapy (Standard Fractionation) Plus Iressa [gefitinib] or Hyperfractionated Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer: A Phase I Pilot Trial

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Sep 2010

At a glance

  • Drugs Cisplatin; Gefitinib
  • Indications Head and neck cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 21 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top